The FDA has posted a warning alerting clinicians of pooled data from 29 placebo-controlled trials of tiotropium that revealed excess strokes among COPD patients on active treatment.

References and Resources
Early Communication about an Ongoing Safety Review of Tiotropium

Sponsored by The Doctor’s Channel